Very structured processes for vendor selection is necessary to improve outcome measurements and data analytics, explained Aaron Lyss, director of value-based care for Tennessee Oncology.
Very structured processes for vendor selection is necessary to improve outcome measurements and data analytics, explained Aaron Lyss, director of value-based care for Tennessee Oncology.
Transcript (slightly modified)
How can practices get better at measuring outcomes and handling data analytics?
The way that we’ve gone about that is to have very structured processes for how we do vendor selection in areas where we need help. So, for example, our ability to analyze claims data and use claims data for quality improvement has grown incredibly fast over the past 15 or so months that we’ve been in the Oncology Care Model. But, it’s still not where we need it to be.
So, there’s a combination of growing the claims data and analytic capabilities internally as quickly as we can, while contracting for outside help with vendors who can really deliver value in meeting the objectives of reducing unnecessary healthcare costs and enhancing the quality of the patient experience.
Dr Kathy Zackowski Discusses the Importance of Rehabilitation Research and Trials in MS
April 26th 2024Kathy Zackowski, PhD, National MS Society, expresses the inherent value of quality rehabilitation trials for broadening clinical understandings of multiple sclerosis (MS) and bettering patient outcomes.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Dr Michael Farwell on FDG PET/CT Imaging to Predict Immunotherapy Response in Advanced Melanoma
April 15th 2024Michael Farwell, MD, associate professor of radiology at the Hospital of the University of Pennsylvania, provides insights into a study on the benefits of using 18F-fluorodeoxyglucose (FDG) PET/CT imaging to detect metabolic tumor changes in skin cancer.
Read More